Meeder Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.86K | Sell |
|
|||||
|
2024
Q4 | $4.98K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $6.4K | Sell |
|
|||||
|
2024
Q1 | $90.8K | Sell |
|
|||||
|
2023
Q4 | $208K | Hold |
|
|||||
|
2023
Q3 | $173K | Hold |
|
|||||
|
2023
Q2 | $185K | Hold |
|
|||||
|
2023
Q1 | $178K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $31K | Sell |
|
|||||
|
2022
Q2 | $61K | Sell |
|
|||||
|
2022
Q1 | $120K | Sell |
|
|||||
|
2021
Q4 | $585K | Sell |
|
|||||
|
2021
Q3 | $707K | Sell |
|
|||||
|
2021
Q2 | $913K | Buy |
|
|||||
|
2021
Q1 | $710K | Buy |
|
|||||
|
2020
Q4 | $11K | Sell |
|
|||||
|
2020
Q3 | $692K | Buy |
|
|||||
|
2020
Q2 | $140K | Sell |
|
|||||
|
2020
Q1 | $105K | Buy |
|
|||||
|
2019
Q4 | $65K | Buy |
|
|||||
|
2019
Q3 | $56K | Buy |
|
|||||
|
2019
Q2 | $58K | Buy |
|
|||||
|
2019
Q1 | $58K | Sell |
|
|||||
|
2018
Q4 | $157K | Buy |
|
|||||
|
2018
Q3 | $117K | Buy |
|
|||||
|
2018
Q2 | $76.6K | Sell |
|
|||||
|
2018
Q1 | $78K | Sell |
|
|||||
|
2017
Q4 | $176K | Sell |
|
|||||
|
2017
Q3 | $622K | Buy |
|
|||||
|
2017
Q2 | $99K | Sell |
|
|||||
|
2017
Q1 | $370K | Sell |
|
|||||
|
2016
Q4 | $537K | Buy |
|
|||||
|
2016
Q3 | $534K | Buy |
|
|||||
|
2016
Q2 | $250K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $2.16M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $220K | Buy |
|